
ASCO endorses adjuvant/salvage RT guideline
The American Society of Clinical Oncology has endorsed the AUA/American Society for Radiation Oncology guideline on the use of adjuvant and salvage radiotherapy after prostatectomy.
The American Society of Clinical Oncology has endorsed the AUA/American Society for Radiation Oncology guideline on the use of adjuvant and salvage radiotherapy after prostatectomy.
The Adjuvant and Salvage Radiotherapy After Prostatectomy: ASTRO/AUA Guideline was
- Physicians should offer adjuvant radiotherapy to patients who have adverse pathologic findings at prostatectomy (ie, seminal vesicle invasion, extensive positive surgical margins) and offer salvage radiotherapy to patients with detectable postoperative PSA or local recurrence after prostatectomy.
- Patients should be informed that, while adjuvant radiotherapy reduces the risk of recurrence and disease progression, its impact on preventing metastases and extending survival is less clear.
- The decision to administer radiotherapy should be made by the patient and the multidisciplinary treatment team with full consideration of the patient's history, values, preferences, quality of life, and functional status.
The guideline is a comprehensive review of 324 research articles of English-language publications published from Jan. 1, 1990 through Dec. 15, 2012. An ASCO guideline endorsement panel determined that the guideline recommendations, published in the
ASCO added one qualifying statement that not all men who are candidates for adjuvant or salvage radiotherapy have the same risk of recurrence or disease progression, and thus, not all men will derive the same benefit from adjuvant radiotherapy. Those at the highest risk for recurrence after radical prostatectomy (including men with seminal vesicle invasion, Gleason score 8 to 10, extensive positive margins, and detectable postoperative PSA) are likely to derive the greatest benefit, ASCO said.
The endorsement was published online in the
Resources for clinicians and patients include:
- podcast for patients with guideline endorsement co-chair Howard Sandler, MD, MS, available at
http://www.cancer.net/blog/2014-11/new-endorsement-asco-radiation-treatment-after-prostatectomy
- the guideline itself, available at
http://www.asco.org/quality-guidelines/adjuvant-and-salvage-radiotherapy-after-prostatectomy-american-society-clinical , along with supplementary materials.
To get weekly news from the leading news source for urologists,
Newsletter
Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.